These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1922537)

  • 1. [Mass screening for breast cancer in women younger than 50; a literature review of the probable effect on mortality].
    Collette HJ; Collette C; Brekelmans CT; de Waard F
    Ned Tijdschr Geneeskd; 1991 Sep; 135(38):1766-7. PubMed ID: 1922537
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening for breast cancer in women younger than 50 years; a literature review of the anticipated effect on mortality].
    Peer PG; Verbeek AL
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):651-5. PubMed ID: 2038380
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening for breast cancer after the age of 70: effect on breast cancer mortality].
    van Dijck JA; Verbeek AL; Hendriks JH; Holland R
    Ned Tijdschr Geneeskd; 1995 Mar; 139(9):428-33. PubMed ID: 7891764
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand?
    Baker S; Wall M; Bloomfield A
    N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening programme on mortality from breast cancer. Investment in treatment would be more cost effective.
    Baum M; Tobias JS
    BMJ; 2000 Dec; 321(7275):1528. PubMed ID: 11118189
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic screening: does it work?
    Handler S
    Minn Med; 2003 Dec; 86(12):6-7. PubMed ID: 14719608
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 11. [The benefit of population screening for breast cancer; an advisory report from the Health Council of the Netherlands].
    van Veen WA; Knottnerus JA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1023-6. PubMed ID: 12073502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for breast cancer in England: past and future.
    Advisory Committee on Breast Cancer Screening
    J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening: a different look at the evidence.
    Wright CJ
    Surgery; 1986 Oct; 100(4):594-8. PubMed ID: 3764685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mammography screening. Senselessly squandered money?].
    Rautenstrauch J
    MMW Fortschr Med; 2000 Mar; 142(12):4-8. PubMed ID: 10804710
    [No Abstract]   [Full Text] [Related]  

  • 15. [Breast cancer screening lacking effectiveness].
    Giard RW; Bonneux LG
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2205-8. PubMed ID: 11757241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population screening for breast cancer: expectations and facts].
    van der Maas PJ
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1740-2. PubMed ID: 1407120
    [No Abstract]   [Full Text] [Related]  

  • 18. What are the benefits and costs of screening mammograms on Kentucky women aged 40-49?
    Spratt JS; Gaines BM; Aaron WS; Cerrito P
    J Surg Oncol; 1996 Oct; 63(2):71-6. PubMed ID: 8888797
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography screening under 50: a limited perspective on a multifaceted issue.
    Royak-Schaler R; Gallant SJ; Klabunde CN
    Womens Health; 1996; 2(4):243-9; discussion 261-6. PubMed ID: 9421559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.